# Specimen and Data Collection for a Novel Biomarker Combination for the Differential Diagnosis of Inflammatory Bowel Disease and Irritable Bowel Syndrome.

> **NCT07471490** · — · ENROLLING_BY_INVITATION · sponsor: **DiaSorin Inc.** · enrollment: 300 (estimated)

## Conditions studied

- IBD (Inflammatory Bowel Disease)
- IBS (Irritable Bowel Syndrome)
- Gastrointestinal Symptoms

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07471490
- **Lead sponsor:** DiaSorin Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2025-05-07
- **Primary completion:** 2026-08-01
- **Final completion:** 2026-09-01
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2026-03-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07471490

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07471490, "Specimen and Data Collection for a Novel Biomarker Combination for the Differential Diagnosis of Inflammatory Bowel Disease and Irritable Bowel Syndrome.". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07471490. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*